Gordhan Heeren M, Milanes Jillian E, Qiu Yijian, Golden Jennifer E, Christensen Kenneth A, Morris James C, Whitehead Daniel C
Department of Chemistry, Clemson University, Clemson, SC, USA.
Eukaryotic Pathogens Innovation Center, Department of Genetics and Biochemistry, Clemson University, Clemson, SC, USA.
Chem Commun (Camb). 2017 Aug 11;53(62):8735-8738. doi: 10.1039/c7cc03378h. Epub 2017 Jul 20.
A new drug delivery strategy was investigated for the development of potent anti-parasitic compounds against Trypanosoma brucei, the causative agent of African sleeping sickness. Thus, potent in vitro hexokinase inhibitors were rendered cytotoxic by appending a tripeptide peroxosomal targeting sequence that facilitated delivery of the molecular cargo to the appropriate organelle in the parasite.
针对非洲昏睡病的病原体布氏锥虫,研究了一种新的药物递送策略,以开发强效抗寄生虫化合物。因此,通过附加一个三肽过氧化物酶体靶向序列,使强效体外己糖激酶抑制剂具有细胞毒性,该序列有助于将分子货物递送至寄生虫中的适当细胞器。